Clinical Trials · NCT03891849
Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock
- Phase
- N/A
- Recruitment status
- Withdrawn
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Enrollment
- 0
- Start date
- Sep 2021
- Locations
- 1 site, France
- Primary endpoint
- Change from baseline of microcirculatory flow index